Search Results 2001-2010 of 16077 for Epilepsy (Partial Onset)

1. A Study to Evaluate the Use of a Novel Wearable Device for Temperature Monitoring in Cancer Patients Who Underwent Autologous Stem Cell Transplant - Mayo Clinic

   ... duration of the study; Subjects able to record body temperature per the protocol for the duration of the study. Exclusion Criteria: Subjects pregnant or ...

2. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate, goserelin acetate, ...

3. Transverse Myelitis Clinical Trials - Mayo Clinic Research

   For example, sex ratio, ethnicity, and age of onset will be described for NMOSD as a whole and amongst the different diagnostic subcategories. A main ...

4. New myelography protocol helps localize cerebrospinal fluid leaks - Mayo Clinic

   Image illustrates the diagnosis of a 61-year-old woman presenting with abrupt onset of Valsalva-related headache. The patient subsequently experienced ...

5. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.

6. Telehealth Assessments With Glioma Receiving Oral Chemotherapy - Mayo Clinic

   Participants who do not have devices that will permit telehealth visits will be provided such tablet devices to facilitate appointments for the duration of the ...

7. Neurology - Clinical trials - Mayo Clinic

   The purpose of this Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is designed to look at disease progression in individuals with early onset ...

8. Publications - Joseph R. Duffy, Jr., Ph.D. - Mayo Clinic

   Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome. Parkinsonism Relat Disord. 2024 Aug; 125:107025 Epub 2024 June ...

9. A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 - Mayo Clinic

   History of seizures within the last 12 months; Current use of anticonvulsants, antipsychotics, systemic steroids and, immunosuppressant therapy. *Use of ...

10. A Study Assessing the Effectiveness and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women who have Advanced Breast Cancer which Progressed on or after Aromatase Inhibitor Treatment - Mayo Clinic

    ... epileptic medications for brain metastases; Has participated in a prior investigational study within 30 days prior to enrollment or within 5 half-lives of ...